Marina M. Demidova

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Prognostic impact of early ventricular fibrillation in patients with ST-elevation myocardial infarction treated with primary PCI

Marina M. Demidova, J. G. Smith, Carl-Johan Höijer et al. · European Heart Journal Acute Cardiovascular Care · 2012 · 62 citations · Full text

Predictors of Ventricular Fibrillation at Reperfusion in Patients With Acute ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention

Marina M. Demidova, Jonas Carlson, David Erlinge et al. · The American Journal of Cardiology · 2014 · 34 citations · Full text

Percutaneous Coronary Intervention, Thrombosis, Ventricular Fibrillation +8

Transient and rapid QRS-widening associated with a J-wave pattern predicts impending ventricular fibrillation in experimental myocardial infarction

Marina M. Demidova, Alba Martín-Yebra, Jesper van der Pals et al. · Heart Rhythm · 2014 · 33 citations · Full text

Electrophysiological Evaluation, Ventricular Fibrillation, Cardiovascular Disease +9